HS LifeSciences
HS LifeSciences, founded in 2008 by biotech veterans, invests in early-stage life sciences companies, focusing on innovative financing models to avoid traditional equity rounds. Geographically flexible.
Funding Stage: Series A/B
Investor type: VC Firm
Investment Areas: venture capital, LifeSciences, Scientific & Academic Research,biotech
Country: Switzerland
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.